Drug Database
Back to search

Czechia· CZ-0209093

EPTIFIBATIDE ACCORD

A eptifibatide product containing eptifibatide, registered in Czechia by Accord Healthcare S.L.U., Barcelona. The same ATC class is registered in 15 of our 19 countries.

ATC B01AC16

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedEPTIFIBATIDE ACCORDATCB01AC16REGISTER NO.CZ-0209093PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eptifibatideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eptifibatide is registered in 15 of 19 countries.

Countries holding a registration under ATC B01AC16 (eptifibatide), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 8 of them publish a price we can compare per daily dose
Search eptifibatide products by name

Eptifibatide · ATC B01AC16

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
EPTIFIBATIDE
Manufacturer
Accord Healthcare S.L.U., Barcelona
Country
Czechia (CZ)
ATC code
B01AC16
ATC class
Eptifibatide
Defined daily dose
0.2 g, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for eptifibatide.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check eptifibatide against other medicinesHow interaction checks work

Eptifibatide · interactions on record

203 records

  • 62 severe
  • 76 moderate
  • 65 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eptifibatide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eptifibatide products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Bulgaria · Ептифибатид Ромфарм
  • Germany · Eptifibatid, Eptifibatid Altamedics
  • Denmark · Eptifibatide "ctruz"
  • Finland · Eptifibatide Ctruz
  • United Kingdom (Northern Ireland) · Eptifibatide Kensington Pharma
  • Hungary · Eptifibatide Rompharm
  • Ireland · Eptifibatide Jed
  • Iceland · Eptifibatide Accord
  • Italy · Eptifibatide Alida
  • Liechtenstein · Eptifibatide Accord
  • Netherlands · Eptifibatide Aftpharm
  • Norway · Eptifibatide Accord, Eptifibatide Ctruz
  • Romania · Eptifibatidă Rompharm
  • Sweden · Eptifibatide Ctruz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/02be2921-c7ef-4eb0-9212-1266fb684249
GET /v1/drugs/02be2921-c7ef-4eb0-9212-1266fb684249?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INF SOL",
  "source": "sukl",
  "strength": "0,75MG/ML",
  "pack_size": "1X100ML",
  "substance": "EPTIFIBATIDE",
  "cz_kod_sukl": "0209093",
  "product_type": null,
  "substance_codes": "15487",
  "registration_state": "R",
  "registration_number": "EU/1/15/1065/001"
}
API referenceMCP serverPlans

See everything about eptifibatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console